Design Therapeutics Inc (DSGN)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
758,490,000
EV to revenue ratio (TTM)
17,818.79
EV to ebitda
-0.836
Financial Performance
Revenue (TTM)
33,000
Gross profit (TTM)
-58,781,000
EBITDA
-78,344,000
Profitability
Operating margin (TTM)
0.00%
Profit margin
0.00%
Return on assets (TTM)
-22.50%
Return on equity (TTM)
-34.10%
Per Share Metrics
Revenue per share (TTM)
0
EPS
-1.18
Diluted EPS (TTM)
-1.18
Book value
3.23
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
29,402.82
Price to book ratio (TTM)
3.832
Growth
Quarterly earnings growth (YoY)
0.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
2
Buy
5
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.663